Our Purpose
About
Science & Medicine
News and Press
Company Statements
Gilead Sciences Response to Open Letter Regarding Access to AmBisome® (liposomal amphotericin B)
Gilead Announces Updates to The Advancing ACCESS® Patient Assistance/Medication Assistance Program
Gilead Sciences Statement on the Passing of the Honorable George P. Shultz, PhD
Gilead Sciences Statement on Recent Events in Washington, D.C.